How to buy Bluejay Diagnostics stock (BJDX)

Bluejay Diagnostics is a medical devices business based in the US. Bluejay Diagnostics shares (BJDX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.80 – a decrease of 2.56% over the previous week. Bluejay Diagnostics employs 10 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Bluejay Diagnostics stock

Buy Bluejay Diagnostics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Bluejay Diagnostics stock price (NASDAQ: BJDX)

Use our graph to track the performance of BJDX stocks over time.

Bluejay Diagnostics shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$3.80
52-week range	$3.03 - $1,260.00
50-day moving average more info button	$4.62
200-day moving average more info button	$103.19
Wall St. target price	$256.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-804.00

Is it a good time to buy Bluejay Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Bluejay Diagnostics price performance over time

Historical closes compared with the close of $3.8 from 2024-12-24

1 week (2024-12-19)	-2.56%
1 month (2024-11-26)	4.97%
3 months (2024-09-26)	2,633.81%
6 months (2024-06-26)	133.13%

1 year (2023-12-26)	46.15%
2 years (2022-12-23)	-99.88%
3 years (2021-12-23)	24880
5 years (2019-12-22)	N/A

Bluejay Diagnostics financials

Gross profit TTM	$48,911
Return on assets TTM	-58.51%
Return on equity TTM	-125.25%
Profit margin	0%
Book value	$18.69
Market Capitalization more info button	$2.3 million

TTM: trailing 12 months

Bluejay Diagnostics share dividends

We're not expecting Bluejay Diagnostics to pay a dividend over the next 12 months.

You may also wish to consider:

• Stryker Corporation (SYK.US) (0.92% forward annual dividend yield)

Have Bluejay Diagnostics's shares ever split?

Bluejay Diagnostics's shares were split on a 1:50 basis on 17 November 2024 . So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Bluejay Diagnostics shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Bluejay Diagnostics shares which in turn could have impacted Bluejay Diagnostics's share price.

Bluejay Diagnostics share price volatility

Over the last 12 months, Bluejay Diagnostics's shares have ranged in value from as little as $3.03 up to $1260. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bluejay Diagnostics's is 0.728. This would suggest that Bluejay Diagnostics's shares are less volatile than average (for this exchange).

To put Bluejay Diagnostics's beta into context you can compare it against those of similar companies.

• Intuitive Surgical (ISRG.US): 1.389
• Stryker Corporation (SYK.US): 0.92
• Edwards Lifesciences (EW.US): 1.12

Bluejay Diagnostics overview

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Frequently asked questions

null
What percentage of Bluejay Diagnostics is owned by insiders or institutions?
Currently 1.146% of Bluejay Diagnostics shares are held by insiders and 0.949% by institutions. How many people work for Bluejay Diagnostics?
Latest data suggests 10 work at Bluejay Diagnostics. When does the fiscal year end for Bluejay Diagnostics?
Bluejay Diagnostics's fiscal year ends in December. Where is Bluejay Diagnostics based?
Bluejay Diagnostics's address is: 360 Massachusetts Avenue, Acton, MA, United States, 01720 What is Bluejay Diagnostics's ISIN number?
Bluejay Diagnostics's international securities identification number is: US0956331039